The Evaluation of Teratogenic Effects of Tramadol on Mouse Fetuses
ELNAZSIROUS, HOSSEIN VATANPOUR, AKRAM ABU TORABI, BAHARAK MOHAMMADZADEH ASL
1155
ABSTRACT
Introduction: Tramadol belongs to the group of
quasi-narcotic compounds and is used as an analgesic drug with central effects
in the treatment of moderate-to-severe acute pain (after surgery and trauma)
and chronic cancer pain, and chronic non‐cancer pain, for example, due to
osteoarthritis. Tramadol is a weak μ-opioid receptor agonist and its analgesic
activity is mainly based on serotonin reuptake inhibition. This drug is a weak
reuptake inhibitor of norepinephrine. It is contraindicated in patients with a
history of seizure disorders, and its use increases serotonin syndrome. Due to
the occurrence of fetal complications, in this study, the probability of the
teratogenic effects of tramadol on the mice embryo was investigated.
Method: Pregnant mice were fed a tramadol dose
of 1-3-9-27-50-100 mg/kg during the 7th to 9th day of pregnancy, and were
anesthetized with isoflurane on the 15th day of pregnancy. The fetuses were
removed to assess the number of miscarriages, fetal and placental weights,
fetal length and placental diameter, liver size and uterine diameter, and
histopathological examination, and were studied for developmental toxicity.
Results: The results of statistical analysis
showed that tramadol significantly reduced fetal weight and fetal length after
exposure to 1-3-9-27-50-100 mg/kg concentrations. However, at a dose of 27
mg/kg, fetal weight and length did not change significantly. The weight of the
placenta increased significantly at a dose of 27 mg/kg, and the weight and
diameter of the placenta decreased significantly at a dose of 100 mg/kg, and
there was a significant increase in uterine horn diameter and endometrial
thickness compared to the control group. Also, histopathological examination
showed that tramadol causes skeletal anomalies and pathological disorders in
the brain, liver, abdominal wall, and placenta.
Conclusion: As a result of the research, the use
of tramadol during pregnancy causes anomalies in fetal development and
histopathological changes in the process of brain and liver development. Therefore,
it is recommended to be careful in taking this drug during pregnancy.
Keywords: Tramadol, Anomaly, Embryonic-Fetal
Toxicity, Developmental Toxicity,mousefetus